About 5,740 results
Open links in new tab
Despite Steep Discounts, Humira Biosimilars Are Priced More Than ...
FDA Approves First Subcutaneous Infliximab Product - Center for …
Center for Biosimilars®
FDA Approves Pavblu for Retinal Conditions
FDA Approves First Biosimilar for Neulasta Onpro - Center for …
Stable Patient Satisfaction Found After Switching From the Humira …
GRx+Biosims: Panelists Discuss Regulatory Shifts in Biosimilar ...
FDA Approves Imuldosa, a Biosimilar to Stelara
Fourth Ustekinumab Biosimilar, Otulfi, Approved in US
Pertuzumab Biosimilar Shows Promise in HER2-Positive Breast …